The 2015 to 2017 outbreak of Zika generated global attention on the risk of a spectrum of neurological disorders posed to women and their unborn children—including, but not limited to ...
Fiocruz builds new hospital center and invests in clinical trials with WHO
The rapid assembly unit will have 200 beds exclusive for treatment of Covid-19. The new space will hold the Solidarity clinical trial.Learn more
Fiocruz President talks about the arrival of the Covid-19 in Brazil
Nísia Trindade Lima comments on the context of the pandemic, its challenges and the institutional response to the health crisis.Learn more
Fiocruz will be helping African countries in the response against the Covid-19
The Foundation will send a team of professionals to Portuguese-speaking countries in Africa to help organize the response to the new coronavirus pandemic.Learn more
[In the press] What is going to happen when the coronavirus hits the slums?
The value of mitigating epidemic peaks of COVID-19 for more effective public health responses
Fiocruz researcher Daniel Antunes Maciel Villela discusses control mesures to reduce the burden of Covid-2019Learn more
Transmission of Covid-19 may have begun in November
Researchers from the Oswaldo Cruz Institute (IOC/Fiocruz) have participated on a study with the goal of clarifying the new coronavirus transmission dynamics and the beginning of the outbreak.Learn more
The Fiocruz response
Fiocruz is the reference institution in Brazil for testing the novel coronavirus (2019-nCoV) and has been working closely with the country´s Ministry of Health (MoH) to ensure timely and reliable diagnostic and response.Learn more
Abstract Background Science studies have been a field of research for different knowledge areas, and they have been successfully used to analyse the construction of scientific knowledge, practice and dissemination ...
The emergence of Zika virus in 2015 challenged conventional ideas of mosquito-borne diseases, tested the resilience of health systems and embedded itself within local sociocultural worlds, with major implications for ...
The global spread of the 2019-nCoV is continuing and is fast moving, as indicated by the WHO raising the risk assessment to high. In this article, we provide a preliminary ...
In an interview to the Fiocruz News Agency (AFN), Nísia Trindade Lima comments on the context of the Covid-19 pandemics and the challenges of its arrival in Brazil. The Fiocruz president also lists some of the actions taken by the ... Read more
The Foundation started the construction, in Rio de Janeiro, of the Hospital Center for the Covid-19 Pandemic - National Institute of Infectious Diseases, which will assist the state and municipal governments in fighting the disease. The rapid assembly hospital unit ... Read more
Starting this week, Brazil will gain a weight boost in the national response to a possible introduction of the 2019-nCoV in the country. Together with PAHO/WHO, specialists from the Laboratory of Respiratory And Measles Virus of the Oswaldo Cruz Institute, ... Read more
On this occasion, Dr. Ventura, talked about the crucial role of health systems to respond to emergencies and the inequalities inherent to emergency declarations issued by the International Health Regulations (IHR, 2005) system. Read more
With the launch of the new Comandante Ferraz Antarctica Station on January 15, Fiocruz now relies on a permanent laboratory in the continent. Fiolab will be a biosafety laboratory prepared to respond to Brazil’s needs regarding epidemiological and public health ... Read more